Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial

First subject enrolled in double-blind placebo-controlled trial

2012-11-13

(Press-News.org) Mountain View, California; November 13, 2012. Edison Pharmaceuticals today announced the initiation of a phase 2B study entitled, "A Phase 2B Randomized, Placebo-Controlled, Double-Blind Clinical Trial of EPI-743 in Children with Leigh Syndrome." Four clinical trial sites have been selected in the United States: Lucile Packard Children's Hospital, Stanford University Medical Center – Palo Alto, California; Akron Children's Hospital – Akron, Ohio; Seattle Children's Hospital – Seattle, Washington; and Texas Children's Hospital, Baylor University – Houston, Texas. The trial is a placebo-controlled study lasting six months, and then extending an additional six months, during which all subjects will receive EPI-743. Subjects must be between one and twelve years old, possess genetic confirmation of Leigh syndrome, and meet certain disease severity criteria. More information on the study specifics is available on ClinicalTrials.gov. The primary endpoint of the clinical trial is the Newcastle Paediatric Mitochondrial Disease Scale. Secondary endpoints include neurologic, muscular, imaging, and biomarker indices. The study design was based on positive phase 2A data recently reported in the journal Molecular Genetics and Metabolism, "EPI-743 reverses the progression of the pediatric mitochondrial disease- genetically defined Leigh Syndrome" 107 (2012) 383-388. ### Leigh Syndrome Leigh syndrome is an inherited lethal, progressive, predominately pediatric, neuromuscular disorder for which there are no approved treatments. Initially described in 1951, the hallmarks of the disease include death of central nervous system regions responsible for the control of breathing and coordination of movement. Leigh syndrome is a member of a larger family of diseases called mitochondrial disease, which share as a common biochemical mechanism defects in cellular energy metabolism. EPI-743 EPI-743 is an orally bioavailable small molecule being developed by Edison Pharmaceuticals for the treatment of Leigh syndrome and other inherited mitochondrial diseases. EPI-743 is a member of the para-benzoquinone class of drugs. It serves as a cofactor for the novel drug target– NADPH quinone oxidase 1 (NQO1). Through a redox-based mechanism, EPI-743 augments endogenous glutathione biosynthesis– essential for the control of oxidative stress. Edison Pharmaceuticals Edison Pharmaceuticals is a specialty pharmaceutical company dedicated to developing treatments for children with orphan mitochondrial diseases. Clinical Study Site Information Akron Children's Hospital
htonni@chmca.org Lucile Packard Children's Hospital, Stanford University Medical Center
kconnors@stanford.edu Seattle Children's Hospital
laurie.guidry@seattlechildrens.org Texas Children's Hospital, Baylor University
catherine.loffredo@bcm.edu Edison Information Edison Pharmaceuticals, Inc.
350 North Bernardo Avenue
Mountain View, CA 94043
info@edisonpharma.com
edisonpharma.com END

ELSE PRESS RELEASES FROM THIS DATE:

A sip of resveratrol and a full p53: Ingredients for a successful cell death

2012-11-13

Rio de Janeiro, Brazil- Resveratrol is a naturally occurring dietary compound found in grapes, berries, and peanuts. This polyphenol protects plants against pathogens such as bacteria and fungi by inducing cell death in invading organisms. The compound was discovered in red wine in 1939 but by large did not attract the attention of the scientific community. More recently, pre-clinical studies have revealed the many beneficial properties of resveratrol. These include antidiabetic, cardioprotective, and chemopreventive effects. The latter has been associated to resveratrol ...

Should hyperbaric oxygen therapy be used to treat combat-related mild traumatic brain injury?

2012-11-13

New Rochelle, NY, November 13, 2012—The average incidence of traumatic brain injury (TBI) among service members deployed in Middle East conflict zones has increased 117% in recent years, mainly due to proximity to explosive blasts. Therapeutic exposure to a high oxygen environment was hoped to minimize the concussion symptoms resulting from mild TBI, but hyperbaric oxygen (HBO2) treatment may not offer significant advantages, according to an article in Journal of Neurotrauma, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free ...

Trying to save money? Ask for crisp new bills at the bank

2012-11-13

Consumers will spend more to get rid of worn bills because they evoke feelings of disgust but are more likely to hold on to crisp new currency, according to a new study in the Journal of Consumer Research. "The physical appearance of money can alter spending behavior. Consumers tend to infer that worn bills are used and contaminated, whereas crisp bills give them a sense of pride in owning bills that can be spent around others," write authors Fabrizio Di Muro (University of Winnipeg) and Theodore J. Noseworthy (University of Guelph). Does the physical appearance of ...

CU-NOAA study shows summer climate change, mostly warming

2012-11-13

Analysis of 90 years of observational data has revealed that summer climates in regions across the globe are changing -- mostly, but not always, warming --according to a new study led by a scientist from the Cooperative Institute for Research in Environmental Sciences headquartered at the University of Colorado Boulder. "It is the first time that we show on a local scale that there are significant changes in summer temperatures," said lead author CIRES scientist Irina Mahlstein. "This result shows us that we are experiencing a new summer climate regime in some regions." The ...

Frustrated FATshionistas: How do plus-sized consumers mobilize to demand better clothing options?

2012-11-13

Marginalized groups of consumers can mobilize as an online community to seek greater inclusion in and more choice from mainstream markets, according to a new study in the Journal of Consumer Research. "In order to gain greater inclusion in the mainstream market, fatshionistas have tried to persuade established companies to serve them better, publicized the offerings of companies that have tried meeting their needs, and looked for opportunities to interact with influential designers and retailers in order to influence them to do more to serve their needs," write authors ...

Can the addition of radiolabeled treatments improve outcomes in advanced metastatic disease?

2012-11-13

New Rochelle, NY, November 12, 2012--Radiolabeled agents are powerful tools for targeting and killing cancer cells and may help improve outcomes and lengthen survival times of patients with advanced disease that has spread beyond the initial tumor site. Effective therapy for metastatic cancer requires a combination of treatments, and the benefits of adding radionuclide therapy are explored in three studies published in Journal of Clinical Investigation, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The articles are available free on the Journal of Clinical ...

Matching brands: Why do consumers prefer Tostitos salsa with Tostitos tortilla chips?

2012-11-13

Consumers prefer matching brands for products that are consumed together because they believe products from the same brand have been designed to go together, according to a new study in the Journal of Consumer Research. "How much do brand combinations affect how much consumers enjoy products that are consumed together? It seems that matching brand labels enhance enjoyment by encouraging consumers to believe that the products were tested and designed to go well together," write authors Ryan Rahinel and Joseph P. Redden (both University of Minnesota). In one study, consumers ...

Nature study reveals loss of essential blood cell gene leads to anemia

2012-11-13

Athens, Ga. – Scientists at the University of Georgia, Harvard Medical School and the University of Utah have discovered a new gene that regulates heme synthesis in red blood cell formation. Heme is the deep-red, iron-containing component of hemoglobin, the protein in red blood cells responsible for transporting oxygen in the blood. The study was published online Nov. 7 and will be in the Nov. 22 print edition of the journal Nature. The findings promise to advance the biomedical community's understanding and treatment of human anemias and mitochondrial diseases, both ...

Novice or expert: How do consumers increase their knowledge about products?

2012-11-13

Consumers seek out novel consumption experiences to increase their knowledge about products but do so selectively based on their level of expertise, according to a new study in the Journal of Consumer Research. "It has been said that experience is the best teacher. Perhaps the lessons learned through trying new experiences can help explain the reason consumers seek out novel experiences that do not necessarily offer the greatest satisfaction?" write authors Joshua J. Clarkson (University of Cincinnati), Chris Janiszewski (University of Florida), and Melissa D. Cinelli ...

Plants and soils could exacerbate climate change as global climate warms

2012-11-13

WASHINGTON — November 13, 2012 — Scientists from the American Meteorological Society (AMS) and University of California, Berkeley have demonstrated that plants and soils could release large amounts of carbon dioxide as global climate warms. This finding contrasts with the expectation that plants and soils will absorb carbon dioxide and is important because that additional carbon release from land surface could be a potent positive feedback that exacerbates climate warming. The study was published today in a Journal of Climate paper titled, "Carbon cycle uncertainty ...

Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: